Sherril S Johnson

Title: The Innovative Mind of Sherril S. Johnson

Introduction

Sherril S. Johnson, based in Santa Cruz, CA, is a prominent inventor recognized for her contributions to the field of hematological research. With one patent to her name, she has made significant strides in developing therapeutic solutions for disorders affecting blood health.

Latest Patents

Sherril's notable patent involves "Peptides and compounds that bind to the thrombopoietin receptor." This invention describes peptides and peptide mimetics that effectively bind to and activate the thrombopoietin receptor. Such technological advancements are particularly beneficial in treating hematological disorders, including thrombocytopenia, which can occur due to chemotherapy, radiation therapy, or bone marrow transfusions. Additionally, her work includes diagnostic methods that utilize labeled peptides and peptide mimetics, showcasing the versatile applications of her research.

Career Highlights

Currently, Sherril S. Johnson works at Glaxo Wellcome Inc., a company renowned for its pharmaceutical innovations. Her role there involves deep engagement with cutting-edge research that aims to improve patient outcomes in hematology. Sherril's commitment to innovation has played a crucial role in her professional journey, establishing her as a key figure in her field.

Collaborations

Throughout her career, Sherril has collaborated with esteemed professionals, including Ronald W. Barrett and William J. Dower. These collaborations have enriched her work and enabled her to push the boundaries of research in hematology, fostering an environment of collective knowledge and innovation.

Conclusion

Sherril S. Johnson exemplifies the spirit of innovation through her dedication to developing effective treatments for hematological disorders. With her groundbreaking patent and collaborative efforts, she continues to make significant contributions to the medical field, inspiring future generations of inventors.